Search results
CRAI Jumps 20% in 3 Months as Demand Broadens Across Key Practices
CRA International, Inc. CRAI shares have gained 20% in the past three months, putting the focus on whether improving business momentum can support the advance. Second-quarter revenue growth, a
RSG Raises 2026 Outlook as Pricing Strength Offsets Softer Volumes
Republic Services, Inc. RSG raised its 2026 financial outlook after second-quarter results showed that pricing and cash generation continued to offset softer volumes. Revenues increased 4.6% year
Is Carnival (CCL) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Middleby (MIDD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2026, Middleby (MIDD) reported revenue of $875.55 million, down 10.5% over the same period last year. EPS came in at $2.35, compared to $2.35 in the year-ago quarter.
The
Sea Limited (SE) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended June 2026, Sea Limited Sponsored ADR (SE) reported revenue of $7.8 billion, up 45.6% over the same period last year. EPS came in at $0.86, compared to $0.85 in the year-ago
Can Micron's Take-or-Pay Deals Improve Revenue Growth Visibility?
Micron Technology, Inc. MU is using take-or-pay agreements to make its memory business more predictable. The strategy is important because DRAM and NAND markets have historically been highly
Should You Buy RSG Stock as Pricing Strength Meets Premium Valuation?
Republic Services, Inc. RSG is sustaining revenue growth through disciplined pricing, even as volumes remain soft in parts of the business. Cash generation and shareholder returns add support to the
Sunoco's $600M Offen Acquisition Expands Fuel Distribution Footprint
Sunoco LP SUN is strengthening its fuel distribution platform with the planned acquisition of Offen Petroleum (Offen) for approximately $600 million in an all-cash transaction. The deal is expected
LifeStance Health Group, Inc. (LFST) Soars to 52-Week High, Time to Cash Out?
A strong stock as of late has been LifeStance Health Group (LFST). Shares have been marching higher, with the stock up 9.4% over the past month. The stock hit a new 52-week high of $12.43 in the
Lifetime Brands, Inc. (LCUT) Hit a 52 Week High, Can the Run Continue?
A strong stock as of late has been Lifetime Brands (LCUT). Shares have been marching higher, with the stock up 5.7% over the past month. The stock hit a new 52-week high of $10.12 in the previous
Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue?
A strong stock as of late has been Biodesix, Inc. (BDSX). Shares have been marching higher, with the stock up 16.1% over the past month. The stock hit a new 52-week high of $25.51 in the previous
Lam Research Enters Panel-Level Packaging: Is This a Growth Catalyst?
Lam Research Corporation LRCX is expanding its opportunity in advanced packaging as artificial intelligence (AI) chips become larger and more complex. The company seems to be now focusing on the
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth
Key Points
- Interested in AdaptHealth Corp.? Here are five stocks we like better.
- AdaptHealth is selling its roughly $600 million diabetes business to Cardinal Health and exiting certain
eToro Group Q2 Earnings Call Highlights
Key Points
- Interested in eToro Group Ltd.? Here are five stocks we like better.
- Q2 financial results improved: Net contribution and adjusted EBITDA each rose 9% year over year to $229 million
Elbit Systems Q2 Earnings Call Highlights
Key Points
- Interested in Elbit Systems Ltd.? Here are five stocks we like better.
- Strong second-quarter performance: Revenue increased 15.9% to $2.287 billion, while GAAP diluted EPS rose 34% to
Electrovaya Q3 Earnings Call Highlights
Key Points
- Interested in Electrovaya Inc.? Here are five stocks we like better.
- Q3 revenue rose modestly to $17.7 million, while gross margin improved to 34.9% and adjusted EBITDA reached a
DarioHealth Q2 Earnings Call Highlights
Key Points
- Interested in DarioHealth Corp.? Here are five stocks we like better.
- Q2 revenue fell to $5.2 million as DarioHealth continued moving away from pharmaceutical services toward
Ceragon Networks Q2 Earnings Call Highlights
Key Points
- Interested in Ceragon Networks Ltd.? Here are five stocks we like better.
- Revenue and bookings accelerated: Second-quarter revenue rose 14.2% year over year to $93.9 million, while
Big Sky Industrial Inc. Common Stock Q2 Earnings Call Highlights
Key Points
- Interested in Big Sky Industrial Inc. Common Stock? Here are five stocks we like better.
- Phase 1 remains on schedule for commissioning later in 2026 and commercial operations in
Bicara Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Bicara Therapeutics Inc.? Here are five stocks we like better.
- FICERA’s pivotal FORTIFI-HN01 trial remains on track for substantial enrollment by the end of 2026, with


